コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 act parathyroid hormone, and increased serum C telopeptide.
3 mor burden of Neo cells, the serum levels of C-telopeptide and TRAP-5b never increase above the level
4 obic interactions involving the short alpha2 C-telopeptide are crucial determinants of its azimuthal
5 asures were type I collagen crosslinked beta C-telopeptide (betaCTX), and type 1 procollagen-N-propep
7 ated peptides indicated that both the N- and C-telopeptides bound to a region between amino acid 776
9 (PTH), bone alkaline phosphatase (BAP), and C-telopeptide (CTX) in youth infected with human immunod
10 These animals have high serum levels of the C-telopeptide derived from type I collagen as well as si
12 links at molecular sites (mediated by N- and C-telopeptide domains) found in collagen II fibrils proc
13 , aldosterone, endothelin-1, troponin I, and C-telopeptide for type I collagen levels, suggesting mor
14 [procollagen III N-terminal peptide], CITP [C-telopeptide for type I collagen], IGFBP7 [insulin-like
15 h serum levels of the bone resorption marker C-telopeptide fragments of type I collagen (CTX), elevat
16 r-maximal reductions in mean levels of serum C-telopeptide from baseline were evident three days afte
17 d characteristics sex, serum type I collagen C-telopeptide, hip bone mineral density, urticaria pigme
18 d mouse skin, species that lack an alpha1(I) C-telopeptide histidine, revealed that HHL is a laborato
20 lagen triple-helical segment followed by the C-telopeptides in their docked conformation, and then th
22 th an increase in bone resorption, the serum C-telopeptide level was 25% higher in transgenic mice th
23 ls of bone resorption (serum type I collagen C-telopeptide), low hip bone mineral density, absence of
24 linked alpha1(I) chains as a result of their C-telopeptide lysines being more completely oxidized to
25 e alkaline phosphatase (b-ALP), and terminal C telopeptide of collagen Type I (CTX) were analyzed.
27 h continuing alendronate: 55.6% (P<.001) for C-telopeptide of type 1 collagen, 59.5% (P < .001) for s
29 sient decrease in the bone resorption marker C-telopeptide of type I collagen (CTX-1) were observed.
30 propeptide of type I procollagen (PINP) and C-telopeptide of type I collagen (CTX-I) are markers of
31 groups had 70% higher levels of cross-linked C-telopeptide of type I collagen, a bone resorption mark
32 raphy and a significant decrease in systemic C-telopeptide of type I collagen, suggesting decreased o
34 inoline, glycosylated Pyr (Glc-Gal-Pyr), and C-telopeptide of type II collagen (CTX-II) was assessed
35 for helical peptide of type II collagen and C-telopeptide of type II collagen, were observed after r
37 ns of 2.5 mM, peptides with sequences in the C-telopeptides of the alpha1(I) and alpha2(I) chain inhi
38 ed at baseline, week 12, and week 28: B-SAP, c-telopeptide, procollagen type I intact N-terminal prop
40 cular fluid (GCF) analysis for the levels of C-telopeptide pyridinoline cross-links (ICTP), and genet
41 ecifically evaluate the relationship between C-telopeptide pyridinoline cross-links and periodontal d
43 idinoline differed between N-telopeptide and C-telopeptide sites, and between the individual intercha
44 ins was cross-linked by pyridinolines at the C-telopeptide to helix site, [alpha1(I)C]2alpha1(I)helix
48 ncentrations of collagen type 1 cross-linked C-telopeptide was significantly decreased in the RCE gro